411 related articles for article (PubMed ID: 8406816)
21. Humoral and cellular immune responses in the murine respiratory tract following oral immunization with cholera toxin or Escherichia coli heat-labile enterotoxin.
Ruedl C; Rieser C; Kofler N; Wick G; Wolf H
Vaccine; 1996 Jun; 14(8):792-8. PubMed ID: 8817827
[TBL] [Abstract][Full Text] [Related]
22. Peyer's patches are required for intestinal immunoglobulin A responses to Salmonella spp.
Hashizume T; Togawa A; Nochi T; Igarashi O; Kweon MN; Kiyono H; Yamamoto M
Infect Immun; 2008 Mar; 76(3):927-34. PubMed ID: 18086815
[TBL] [Abstract][Full Text] [Related]
23. Strong differential regulation of serum and mucosal IgA responses as revealed in CD28-deficient mice using cholera toxin adjuvant.
Gärdby E; Wrammert J; Schön K; Ekman L; Leanderson T; Lycke N
J Immunol; 2003 Jan; 170(1):55-63. PubMed ID: 12496383
[TBL] [Abstract][Full Text] [Related]
24. Mucosal immunity: regulation by helper T cells and a novel method for detection.
Jackson RJ; Marinaro M; VanCott JL; Yamamoto M; Okahashi N; Fujihashi K; Kiyono H; Chatfield SN; McGhee JR
J Biotechnol; 1996 Jan; 44(1-3):209-16. PubMed ID: 8717406
[TBL] [Abstract][Full Text] [Related]
25. Transcutaneous immunization with bacterial ADP-ribosylating exotoxins as antigens and adjuvants.
Glenn GM; Scharton-Kersten T; Vassell R; Matyas GR; Alving CR
Infect Immun; 1999 Mar; 67(3):1100-6. PubMed ID: 10024549
[TBL] [Abstract][Full Text] [Related]
26. Differential effect of aging on B-cell immune responses to cholera toxin in the inductive and effector sites of the mucosal immune system.
Haq JA; Szewczuk MR
Infect Immun; 1991 Sep; 59(9):3094-100. PubMed ID: 1879933
[TBL] [Abstract][Full Text] [Related]
27. Recombinant cholera toxin B subunit is not an effective mucosal adjuvant for oral immunization of mice against Helicobacter felis.
Blanchard TG; Lycke N; Czinn SJ; Nedrud JG
Immunology; 1998 May; 94(1):22-7. PubMed ID: 9708182
[TBL] [Abstract][Full Text] [Related]
28. Induction of pneumococcal polysaccharide-specific mucosal immune responses by oral immunization.
VanCott JL; Kobayashi T; Yamamoto M; Pillai S; McGhee JR; Kiyono H
Vaccine; 1996 Apr; 14(5):392-8. PubMed ID: 8735550
[TBL] [Abstract][Full Text] [Related]
29. Oral but not parenteral interleukin (IL)-12 redirects T helper 2 (Th2)-type responses to an oral vaccine without altering mucosal IgA responses.
Marinaro M; Boyaka PN; Finkelman FD; Kiyono H; Jackson RJ; Jirillo E; McGhee JR
J Exp Med; 1997 Feb; 185(3):415-27. PubMed ID: 9053442
[TBL] [Abstract][Full Text] [Related]
30. Mesenteric lymph nodes are not required for an intestinal immunoglobulin A response to oral cholera toxin.
Hahn A; Thiessen N; Pabst R; Buettner M; Bode U
Immunology; 2010 Mar; 129(3):427-36. PubMed ID: 19922419
[TBL] [Abstract][Full Text] [Related]
31. Mucosal immunogenicity and adjuvanticity of cholera toxin in swine.
Foss DL; Murtaugh MP
Vaccine; 1999 Feb; 17(7-8):788-801. PubMed ID: 10067684
[TBL] [Abstract][Full Text] [Related]
32. Protective mucosal immunity in aging is associated with functional CD4+ T cells in nasopharyngeal-associated lymphoreticular tissue.
Hagiwara Y; McGhee JR; Fujihashi K; Kobayashi R; Yoshino N; Kataoka K; Etani Y; Kweon MN; Tamura S; Kurata T; Takeda Y; Kiyono H; Fujihashi K
J Immunol; 2003 Feb; 170(4):1754-62. PubMed ID: 12574339
[TBL] [Abstract][Full Text] [Related]
33. Immune response of the female rat genital tract after oral and local immunization with keyhole limpet hemocyanin conjugated to the cholera toxin B subunit.
Menge AC; Michalek SM; Russell MW; Mestecky J
Infect Immun; 1993 May; 61(5):2162-71. PubMed ID: 8478106
[TBL] [Abstract][Full Text] [Related]
34. Mucosal and systemic immune responses of mice to tetanus toxoid coadministered nasally with AFCo1.
Romeu B; González E; Del Campo J; Acevedo R; Zayas C; Valdés Y; Cabrera O; Cuello M; Balboa J; Lastre M; Pérez O
Can J Microbiol; 2011 Mar; 57(3):256-61. PubMed ID: 21358768
[TBL] [Abstract][Full Text] [Related]
35. Toll-like receptor 5 is not essential for the promotion of secretory immunoglobulin A antibody responses to flagellated bacteria.
Hashizume-Takizawa T; Yamamoto M
Microbiol Immunol; 2015 Dec; 59(12):716-23. PubMed ID: 26564803
[TBL] [Abstract][Full Text] [Related]
36. Oral immunization with the saliva-binding region of Streptococcus mutans AgI/II genetically coupled to the cholera toxin B subunit elicits T-helper-cell responses in gut-associated lymphoid tissues.
Toida N; Hajishengallis G; Wu HY; Russell MW
Infect Immun; 1997 Mar; 65(3):909-15. PubMed ID: 9038296
[TBL] [Abstract][Full Text] [Related]
37. Preparation and preclinical evaluation of experimental group B streptococcus type III polysaccharide-cholera toxin B subunit conjugate vaccine for intranasal immunization.
Shen X; Lagergård T; Yang Y; Lindblad M; Fredriksson M; Holmgren J
Vaccine; 2000 Nov; 19(7-8):850-61. PubMed ID: 11115709
[TBL] [Abstract][Full Text] [Related]
38. CD19-deficient mice exhibit poor responsiveness to oral immunization despite evidence of unaltered total IgA levels, germinal centers and IgA-isotype switching in Peyer's patches.
Gärdby E; Lycke NY
Eur J Immunol; 2000 Jul; 30(7):1861-71. PubMed ID: 10940875
[TBL] [Abstract][Full Text] [Related]
39. A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity.
Yamamoto S; Kiyono H; Yamamoto M; Imaoka K; Fujihashi K; Van Ginkel FW; Noda M; Takeda Y; McGhee JR
Proc Natl Acad Sci U S A; 1997 May; 94(10):5267-72. PubMed ID: 9144226
[TBL] [Abstract][Full Text] [Related]
40. Adoptive transfer of gut mucosal antitoxin memory by isolated B cells 1 year after oral immunization with cholera toxin.
Lycke N; Holmgren J
Infect Immun; 1989 Apr; 57(4):1137-41. PubMed ID: 2784416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
